| Title: |
2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test |
| Authors: |
Loverix, Liselore; Vergote, Ignace; Vanderstichele, Adriaan; Busschaert, Pieter; Boeckx, Bram; Venken, Tom; van Nieuwenhuysen, Els; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Lambrechts, Diether; van Gorp, Toon |
| Source: |
Ovarian cancer ; page A340.2-A341 |
| Publisher Information: |
BMJ Publishing Group Ltd |
| Publication Year: |
2022 |
| Document Type: |
conference object |
| Language: |
unknown |
| DOI: |
10.1136/ijgc-2022-esgo.724 |
| DOI: |
10.1136/ijgc-2022-ESGO.724 |
| Availability: |
https://doi.org/10.1136/ijgc-2022-esgo.724; https://syndication.highwire.org/content/doi/10.1136/ijgc-2022-ESGO.724 |
| Accession Number: |
edsbas.73A89841 |
| Database: |
BASE |